NasdaqGS:FLDM

Stock Analysis Report

Executive Summary

Fluidigm Corporation creates, manufactures, and markets technologies and tools for life sciences research in the United States and Europe.

Snowflake

Fundamentals

Flawless balance sheet and overvalued.


Similar Companies

Share Price & News

How has Fluidigm's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: FLDM's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

-7.2%

FLDM

3.9%

US Life Sciences

0.9%

US Market


1 Year Return

-72.0%

FLDM

22.0%

US Life Sciences

16.8%

US Market

Return vs Industry: FLDM underperformed the US Life Sciences industry which returned 22% over the past year.

Return vs Market: FLDM underperformed the US Market which returned 16.8% over the past year.


Shareholder returns

FLDMIndustryMarket
7 Day-7.2%3.9%0.9%
30 Day-51.8%7.2%4.5%
90 Day-60.0%5.3%6.2%
1 Year-72.0%-72.0%22.2%22.0%19.4%16.8%
3 Year-62.0%-62.0%96.5%94.8%47.5%38.0%
5 Year-92.6%-92.6%119.2%116.1%62.0%44.1%

Price Volatility Vs. Market

How volatile is Fluidigm's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Fluidigm undervalued compared to its fair value and its price relative to the market?

0.99x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate FLDM's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate FLDM's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: FLDM is unprofitable, so we can't compare its PE Ratio to the Life Sciences industry average.

PE vs Market: FLDM is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate FLDM's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: FLDM is good value based on its PB Ratio (1x) compared to the US Life Sciences industry average (4.9x).


Next Steps

Future Growth

How is Fluidigm forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?

22.2%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: FLDM is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: FLDM is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: FLDM is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: FLDM's revenue (11.2% per year) is forecast to grow faster than the US market (7.3% per year).

High Growth Revenue: FLDM's revenue (11.2% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: FLDM is forecast to be unprofitable in 3 years.


Next Steps

Past Performance

How has Fluidigm performed over the past 5 years?

-4.5%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: FLDM has high quality earnings.

Growing Profit Margin: FLDM is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: FLDM is unprofitable, and losses have increased over the past 5 years at a rate of -4.5% per year.

Accelerating Growth: Unable to compare FLDM's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: FLDM is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (37.2%).


Return on Equity

High ROE: FLDM has a negative Return on Equity (-41.13%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Next Steps

Financial Health

How is Fluidigm's financial position?


Financial Position Analysis

Short Term Liabilities: FLDM's short term assets ($96.6M) exceeds its short term liabilities ($33.4M)

Long Term Liabilities: FLDM's short term assets ($96.6M) exceeds its long term liabilities (73.4M)


Debt to Equity History and Analysis

Debt Level: FLDM's debt to equity ratio (30.7%) is considered satisfactory.

Reducing Debt: FLDM's debt to equity ratio has reduced from 126.5% to 30.7% over the past 5 years.


Balance Sheet

Inventory Level: FLDM has a low level of unsold assets or inventory.

Debt Coverage by Assets: FLDM's debt is covered by short term assets (assets are 1.9x debt).


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: FLDM has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: FLDM has sufficient cash runway for 1.574127 years if free cash flow continues to grow at historical rates of 18% each year.


Next Steps

Dividend

What is Fluidigm's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%1.4%markettop25%3.7%industryaverage0.4%forecastin3Years0%

Current dividend yield vs market & industry

Notable Dividend: Unable to evaluate FLDM's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate FLDM's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if FLDM's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if FLDM's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of FLDM's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

What is the CEO of Fluidigm's salary, the management and board of directors tenure and is there insider trading?

2.7yrs

Average management tenure


CEO

Chris Linthwaite (46yo)

3.1yrs

Tenure

US$2,585,208

Compensation

Mr. Stephen Christopher Linthwaite, also known as Chris, has been the President of Fluidigm Corporation since August 4, 2016. Mr. Linthwaite has been the Chief Executive Officer of Fluidigm Corporation si ...


CEO Compensation Analysis

Compensation vs Market: Chris's total compensation ($USD2.59M) is above average for companies of similar size in the US market ($USD1.14M).

Compensation vs Earnings: Chris's compensation has increased whilst the company is unprofitable.


Management Age and Tenure

2.7yrs

Average Tenure

45.5yo

Average Age

Experienced Management: FLDM's management team is considered experienced (2.7 years average tenure).


Board Age and Tenure

12.9yrs

Average Tenure

64.5yo

Average Age

Experienced Board: FLDM's board of directors are seasoned and experienced ( 12.9 years average tenure).


Insider Trading

Insider Buying: FLDM insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

SellUS$3,116,86419 Sep 19
Levin Easterly Partners LLC
EntityCompany
Shares577,197
Max PriceUS$5.40
SellUS$64,11213 Sep 19
Levin Easterly Partners LLC
EntityCompany
Shares11,545
Max PriceUS$5.56
BuyUS$10,37229 Aug 19
Samuel Colella
EntityIndividual
Role
Chairman of the Board
Chairman of the Board
Shares2,000
Max PriceUS$5.19
BuyUS$22,07727 Aug 19
Stephen Linthwaite
EntityIndividual
Role
Chief Executive Officer
President
Shares4,000
Max PriceUS$5.52
SellUS$1,059,28215 Aug 19
Levin Easterly Partners LLC
EntityCompany
Shares151,011
Max PriceUS$7.01
SellUS$892,06012 Aug 19
Levin Easterly Partners LLC
EntityCompany
Shares129,237
Max PriceUS$6.90
BuyUS$6,65312 Aug 19
Samuel Colella
EntityIndividual
Role
Chairman of the Board
Chairman of the Board
Shares1,000
Max PriceUS$6.65
BuyUS$63,04009 Aug 19
Samuel Colella
EntityIndividual
Role
Chairman of the Board
Chairman of the Board
Shares9,000
Max PriceUS$7.02
SellUS$19,95605 Aug 19
Levin Easterly Partners LLC
EntityCompany
Shares1,629
Max PriceUS$12.25
SellUS$3,435,24229 Jul 19
Levin Easterly Partners LLC
EntityCompany
Shares287,972
Max PriceUS$11.97
SellUS$1,257,32024 Jul 19
Levin Easterly Partners LLC
EntityCompany
Shares108,123
Max PriceUS$11.78
SellUS$4,553,60419 Jul 19
Levin Easterly Partners LLC
EntityCompany
Shares398,068
Max PriceUS$11.50
SellUS$2,298,25802 Jul 19
Levin Easterly Partners LLC
EntityCompany
Shares186,759
Max PriceUS$12.37
SellUS$2,666,66027 Jun 19
Levin Easterly Partners LLC
EntityCompany
Shares217,148
Max PriceUS$12.35
BuyUS$4,93526 Dec 18
Levin Capital Strategies, L.P.
EntityCompany
Shares661
Max PriceUS$7.79
BuyUS$1,28420 Dec 18
Levin Capital Strategies, L.P.
EntityCompany
Shares164
Max PriceUS$7.86
BuyUS$32018 Dec 18
Levin Capital Strategies, L.P.
EntityCompany
Shares41
Max PriceUS$7.81
BuyUS$6,750,00014 Dec 18
Levin Capital Strategies, L.P.
EntityCompany
Shares1,000,000
Max PriceUS$6.75
BuyUS$270,46211 Dec 18
Levin Capital Strategies, L.P.
EntityCompany
Shares35,033
Max PriceUS$7.95

Ownership Breakdown

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 53.3%.


Management Team

  • Vikram Jog (63yo)

    CFO & Principal Accounting Officer

    • Tenure: 11.8yrs
    • Compensation: US$1.13m
  • Steve Quake

    Co-Founder & Chairman of Advisory Board

    • Tenure: 0yrs
  • Nick Khadder (45yo)

    Senior VP

    • Tenure: 3.4yrs
    • Compensation: US$1.09m
  • Chris Linthwaite (46yo)

    President

    • Tenure: 3.1yrs
    • Compensation: US$2.59m
  • Agnes Lee

    Vice President of Investor Relations

    • Tenure: 0yrs
  • Brad Kreger (44yo)

    Senior Vice President of Global Operations

    • Tenure: 1.6yrs
    • Compensation: US$995.20k
  • Mark Spearman

    Senior Director of Corporate Communications

    • Tenure: 0yrs
  • Angela Peters

    Vice President of Global Human Resources

    • Tenure: 2.3yrs
  • Colin McCracken

    Chief Commercial Officer

    • Tenure: 0.7yrs
  • Andrew Quong

    Chief Science Officer

    • Tenure: 0.4yrs

Board Members

  • Sam Colella (79yo)

    Chairman of the Board

    • Tenure: 19.3yrs
    • Compensation: US$164.78k
  • Steve Quake

    Co-Founder & Chairman of Advisory Board

    • Tenure: 0yrs
  • Pat Jones (75yo)

    Independent Director

    • Tenure: 8.7yrs
    • Compensation: US$127.78k
  • Nicolas Barthelemy (53yo)

    Independent Director

    • Tenure: 2.7yrs
    • Compensation: US$124.78k
  • Frank McCormick (69yo)

    Member of Advisory Board

    • Tenure: 12.9yrs
  • Richard Zare

    Member of Advisory Board

    • Tenure: 18.9yrs
  • Howard Shapiro

    Member of Advisory Board

    • Tenure: 19.9yrs
  • James Berger

    Member of Advisory Board

    • Tenure: 17.4yrs
  • Carlos Paya (60yo)

    Independent Director

    • Tenure: 2.7yrs
    • Compensation: US$112.78k
  • Chris Linthwaite (46yo)

    President

    • Tenure: 3.1yrs
    • Compensation: US$2.59m

Company Information

Fluidigm Corporation's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Fluidigm Corporation
  • Ticker: FLDM
  • Exchange: NasdaqGS
  • Founded: 1999
  • Industry: Life Sciences Tools and Services
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$161.391m
  • Shares outstanding: 69.56m
  • Website: https://www.fluidigm.com

Number of Employees


Location

  • Fluidigm Corporation
  • 7000 Shoreline Court
  • Suite 100
  • South San Francisco
  • California
  • 94080
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
FLDMNasdaqGS (Nasdaq Global Select)YesCommon StockUSUSDFeb 2011
FLBDB (Deutsche Boerse AG)YesCommon StockDEEURFeb 2011

Biography

Fluidigm Corporation creates, manufactures, and markets technologies and tools for life sciences research in the United States and Europe. It offers analytical systems comprising Helios, a CyTOF system, Hy ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/11/20 00:20
End of Day Share Price2019/11/19 00:00
Earnings2019/09/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.